Other languages BioAdaptives, Inc.

Equities

BDPT

US09072U1079

Market Closed - OTC Markets Other stock markets 01:29:04 17/05/2024 am IST			5-day change	1st Jan Change
0.0005 ^USD	0.00%		+25.00%	0.00%

10/04	BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
22/02	Bioadaptives, Inc. Announces Naturacomplete?, an All-In-One Supplement to Optimize Its Ai-Based FYO Obesity Management System	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	10/04
Bioadaptives, Inc. Announces Naturacomplete?, an All-In-One Supplement to Optimize Its Ai-Based FYO Obesity Management System	22/02
BioAdaptives Announces Signing of a New Distributor?s Agreement for AI Body Composition Measuring App and New Weight Management System	17/01
BioAdaptives Inc. Announces the Development of PROTEINnMORETM	14/12
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula	16/11
BioAdaptives, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
BioAdaptives, Inc. Highlights Continued Success of Popular LUNG ARMOR System as US Enters Flu Season	09/11
BioAdaptives, Inc. Announces Nationwide Launch of Lung Fortress Natural Supplement	10/23/10
BioAdaptives, Inc. Commences Development of A New Supplement for Women?S Health	05/23/05
BioAdaptives, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	12/23/12
BioAdaptives, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12
BioAdaptives, Inc. Announces the Appointment of David Allen to its Board of Directors	13/23/13
BioAdaptives, Inc. Signs Non-Exclusive Marketing Agreement with World Wellness, LLC	06/23/06
BioAdaptives, Inc. Announces the Appointment of Dr. Yaguang Liu to its Board of Directors	05/23/05
BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01
BioAdaptives, Inc. Auditor Raises 'Going Concern' Doubt	31/23/31
BioAdaptives Signs Non-Exclusive License with LY Research to Market Patented Product for Glucose Management	28/23/28
BioAdaptives, Inc. Establishes A Wholesale Division to Expand Marketing Presence in USD 151.9 Billion Global Dietary Supplement Market	08/22/08
BioAdaptives, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15
BioAdaptives, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/22/12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages BioAdaptives, Inc.

Equities

BDPT

US09072U1079

Other languages

Filters